Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Mediclinic International Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Mediclinic International şirketinin toplam hissedar öz sermayesi £3.7B ve toplam borcu £2.0B olup, bu da borç-öz sermaye oranını 54.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla £7.9B ve £4.2B dir. Mediclinic International 'in FAVÖK'ü £274.0M faiz karşılama oranı 4.1 dur. Şirketin £454.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

54.1%

Borç/özkaynak oranı

UK£1.99b

Borç

Faiz karşılama oranı	4.1x
Nakit	UK£454.00m
Eşitlik	UK£3.67b
Toplam yükümlülükler	UK£4.21b
Toplam varlıklar	UK£7.88b

Son finansal sağlık güncellemeleri

Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly

Jun 28

Recent updates

Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today

Jul 26

Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?

Sep 08

Is Mediclinic International (LON:MDC) Using Too Much Debt?

Jun 21

Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?

May 26

If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%

Mar 17

What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?

Feb 26

Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability

Feb 11

Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?

Jan 27

Estimating The Fair Value Of Mediclinic International plc (LON:MDC)

Jan 18

These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively

Jan 01

A Look At Mediclinic International's (LON:MDC) Share Price Returns

Dec 17

Our View On Mediclinic International's (LON:MDC) CEO Pay

Dec 02

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: MDC 'nin kısa vadeli varlıkları ( £1.6B ) kısa vadeli yükümlülüklerini ( £1.0B ) aşıyor.

Uzun Vadeli Yükümlülükler: MDC 'un kısa vadeli varlıkları ( £1.6B ) uzun vadeli yükümlülüklerini ( £3.2B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: MDC 'nin net borç/öz sermaye oranı ( 41.7% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: MDC şirketinin borç/öz sermaye oranı son 5 yılda 49.8% seviyesinden 54.1% seviyesine yükseldi.

Borç Kapsamı: MDC 'nin borcu işletme nakit akışı ( 23.7% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: MDC 'in borcuna ilişkin faiz ödemeleri EBIT ( 4.1 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Mediclinic International Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Financial Conduct Authority Cancels the Listing of Mediclinic Shares on the London Stock Exchange and Delisting of Shares from the JSE and the NSX Expects to Take Effect on 7 June 2023

Mediclinic International's Cancellation of Shares from Official List and Main Market of LSE Expected to Take on 30 May 2023; Delisting of Shares from JSE and NSX Expected to Take Effect from Commencement of Trade on 7 June 2023

Cancellation of Listing of Mediclinic Shares on the LSE Is Expected on 26 May 2023

Mediclinic International plc to Delist

Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly

Mediclinic International Ordinary Shares to Be Deleted from OTC Equity

Recent updates

Financial Conduct Authority Cancels the Listing of Mediclinic Shares on the London Stock Exchange and Delisting of Shares from the JSE and the NSX Expects to Take Effect on 7 June 2023

Mediclinic International's Cancellation of Shares from Official List and Main Market of LSE Expected to Take on 30 May 2023; Delisting of Shares from JSE and NSX Expected to Take Effect from Commencement of Trade on 7 June 2023

Mediclinic International plc(LSE:MDC) dropped from FTSE 350 (Ex Investment Companies) Index (GBP)

Cancellation of Listing of Mediclinic Shares on the LSE Is Expected on 26 May 2023

Mediclinic International plc (LSE:MDC) acquired Artisan Biomed.

Mediclinic International plc Approves Final Cash Dividend, Payable on 26 August 2022

Mediclinic International plc to Delist

Mediclinic International plc Approves Final Cash Dividend

Upcoming dividend of UK£0.03 per share

Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today

Estimating The Intrinsic Value Of Mediclinic International plc (LON:MDC)

Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly

Remgro Wants Equal Partner in Possible Mediclinic Buyout

Price target increased to UK£4.26

Price target increased to UK£4.09

Mediclinic International Ordinary Shares to Be Deleted from OTC Equity

Independent Non-Executive Director recently bought UK£73k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Mediclinic International plc to Report First Half, 2023 Results on Nov 16, 2022

High number of new directors

Mediclinic International plc to Report Fiscal Year 2022 Results on May 25, 2022

Are Investors Undervaluing Mediclinic International plc (LON:MDC) By 50%?

High number of new directors

Is Mediclinic International (LON:MDC) Using Too Much Debt?

High number of new directors

Mediclinic International (LON:MDC) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings released: EPS UK£0.088 (vs UK£0.02 in 1H 2021)

High number of new directors

High number of new directors

Senior Independent Director J. Grieve has left the company

Independent Non-Executive Director Trevor Petersen has left the company

Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.43 loss in FY 2020)

Is Mediclinic International (LON:MDC) Using Too Much Debt?

Consensus forecasts updated

Mediclinic International plc Provides Revenue Guidance for Fiscal 2022

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.43 loss in FY 2020)

Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?

If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%

New 90-day high: UK£3.06

What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?

Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability

Non-Executive Director recently sold UK£52k worth of stock

Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?

Estimating The Fair Value Of Mediclinic International plc (LON:MDC)

These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively

A Look At Mediclinic International's (LON:MDC) Share Price Returns

Our View On Mediclinic International's (LON:MDC) CEO Pay

First half 2021 earnings released: EPS UK£0.02

Revenue beats expectations, earnings disappoint

New 90-day high: UK£3.19

New 90-day high: UK£2.95

New 90-day low - UK£2.46

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin